Susquehanna International Group’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $189K | Buy |
308,906
+181,946
| +143% | +$111K | ﹤0.01% | 5588 |
|
2025
Q1 | $72.4K | Sell |
126,960
-19,802
| -13% | -$11.3K | ﹤0.01% | 5951 |
|
2024
Q4 | $210K | Buy |
146,762
+136,423
| +1,319% | +$195K | ﹤0.01% | 5256 |
|
2024
Q3 | $20K | Sell |
10,339
-32,679
| -76% | -$63.1K | ﹤0.01% | 5406 |
|
2024
Q2 | $133K | Sell |
43,018
-11,435
| -21% | -$35.4K | ﹤0.01% | 4983 |
|
2024
Q1 | $285K | Sell |
54,453
-29,870
| -35% | -$156K | ﹤0.01% | 4236 |
|
2023
Q4 | $273K | Buy |
+84,323
| New | +$273K | ﹤0.01% | 4630 |
|
2023
Q3 | – | Sell |
-71,568
| Closed | -$420K | – | 6360 |
|
2023
Q2 | $420K | Buy |
71,568
+10,915
| +18% | +$64.1K | ﹤0.01% | 3846 |
|
2023
Q1 | $173K | Buy |
60,653
+40,053
| +194% | +$114K | ﹤0.01% | 4964 |
|
2022
Q4 | $41.4K | Buy |
+20,600
| New | +$41.4K | ﹤0.01% | 5211 |
|